Night blindness, is a disorder in which your eyes are unable to adjust to low light circumstances. Night blindness is most commonly caused by abnormalities with your rod cells, but it can also be caused by a variety of other factors. Night blindness affects people's ability to see in dimly lit areas or at night. The treatment for night blindness is entirely dependent on the underlying reason. It is caused by a variety of illnesses that cause the retina's rods to degenerate. It is also termed as nyctalopia. This condition is characterized by eye pain vomiting, cloudy vision, halos, light sensitivity, distance vision problem, and headache.
This report contains market size and forecasts of Night Blindness Treatment in Global, including the following market information:
Global Night Blindness Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Night Blindness Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vitamin AD Drops Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Night Blindness Treatment include Merck, Pfizer, GlaxoSmithKline, Johnson & Johnson Private Limited, Roche Holding AG, Abbott, Mylan, Teva Pharmaceuticals and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Night Blindness Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Night Blindness Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Night Blindness Treatment Market Segment Percentages, by Type, 2021 (%)
Vitamin AD Drops
Vitamin AD Softgels
Vitamin A Capsule
Global Night Blindness Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Night Blindness Treatment Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Global Night Blindness Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Night Blindness Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Night Blindness Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Night Blindness Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
GlaxoSmithKline
Johnson & Johnson Private Limited
Roche Holding AG
Abbott
Mylan
Teva Pharmaceuticals
Sanofi
Novartis
Bayer
Sun Pharmaceutical Industries
Aurobindo Pharma
Lupin pharma
Eli Lilly and Company
Sumitomo Dainippon Pharma
Leo Pharma
Bausch Health
AstraZeneca
Cipla